Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset

Our Bureau

Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive license agreement with Vanderbilt University for the rights to a xenogeneic cross-circulation platform that restores damaged donor organs to transplant condition. The donor organ shortage remains dire: Every 8 minutes another person […]

Subscribe Now